Statistical Methods for Analysis of Radiation Effects with Tumor and Dose Location‐Specific Information with Application to the WECARE Study of Asynchronous Contralateral Breast Cancer
暂无分享,去创建一个
Bryan Langholz | Duncan C Thomas | John D Boice | Xinbo Zhang | Marilyn Stovall | Susan A Smith | Roy E Shore | Leslie Bernstein | Charles F Lynch | Jonine L Bernstein | D. Thomas | J. Boice | L. Bernstein | B. Langholz | R. Shore | M. Stovall | J. Bernstein | C. Lynch | Xinbo Zhang | Susan A. Smith
[1] A. Broeks,et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. , 2003, Journal of the National Cancer Institute.
[2] Cancer in the contralateral breast after radiotherapy for breast cancer. , 1992, The New England journal of medicine.
[3] C. Eggers,et al. CANCER OF THE BREAST , 1941, Annals of surgery.
[4] B G Armstrong,et al. The effects of measurement errors on relative risk regressions. , 1990, American journal of epidemiology.
[5] M. Stovall,et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.
[6] John D Boice,et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. , 2002, Journal of the National Cancer Institute.
[7] B. Haffty,et al. The Location of Contralateral Breast Cancers After Radiation Therapy , 2001, The breast journal.
[8] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[9] J. Boice,et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. , 2008, International journal of radiation oncology, biology, physics.
[10] Marilyn Stovall,et al. Dose Reconstruction for Therapeutic and Diagnostic Radiation Exposures: Use in Epidemiological Studies , 2006, Radiation research.
[11] W. Morgan,et al. Non-targeted bystander effects induced by ionizing radiation. , 2007, Mutation research.
[12] W D Flanders,et al. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! , 1996, American journal of epidemiology.
[13] J. Fraumeni,et al. Lung Cancer after Treatment for Hodgkin's Disease: Focus on Radiation Effects , 2003, Radiation research.
[14] Duncan C. Thomas. General relative-risk models for survival time and matched case-control analysis , 1981 .
[15] D. Loomis,et al. Varied Forms of Bias Due to Nondifferential Error in Measuring Exposure , 1994, Epidemiology.
[16] J. Klein,et al. Statistical Models Based On Counting Process , 1994 .
[17] Bryan Langholz,et al. Methods for the Analysis of Sampled Cohort Data in the Cox Proportional Hazards Model , 1995 .
[18] Bryan Langholz,et al. Risk set sampling in epidemiologic cohort studies , 1996 .
[19] Erik Holmberg,et al. Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts , 2002, Radiation research.
[20] R. Pyke,et al. Logistic disease incidence models and case-control studies , 1979 .
[21] D. Cox. Regression Models and Life-Tables , 1972 .
[22] E Cardis,et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. , 1995, Radiation research.
[23] P Fraser,et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. , 1987, Journal of the National Cancer Institute.
[24] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[25] N. Keiding,et al. Survival models and martingale dynamics: original text, discussion and reply , 1989 .
[26] M. Laberge. [Cancer of the breast]. , 1961, Laval medical.
[27] Bryan Langholz,et al. Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study , 2004, Breast Cancer Research.
[28] W. den Otter,et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1988, The New England journal of medicine.
[29] J. Wakefield,et al. The interpretation of exposure effect estimates in chronic air pollution studies , 2007, Statistics in medicine.